Welcome!

Cognitive Computing Authors: William Schmarzo, Elizabeth White, Pat Romanski, Liz McMillan, Yeshim Deniz

News Feed Item

Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2014-2024

NEW YORK, Jan. 6, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2014-2024

http://www.reportlinker.com/p0572966/Pharmaceutical-Anti-counterfeiting-Technologies-Market-Analysis-2014-2024.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical

Report Details

Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2014-2024 - your guide to developments, opportunities and revenues

Where is the pharmaceutical anti-counterfeiting industry heading? Visiongain's brand new report lets you assess forecasted sales at overall world market, submarket, and national level to 2024.

Our 169 page study investigates technologies to tackle drug counterfeiters. Discover the most lucrative areas in that industry and market, seeing future outlooks.

Forecasts from 2014-2024 and other analyses show you commercial prospects

Besides revenue forecasting to 2024, our new study provides you with historical data, recent results, growth rates, and market shares. There you find original analyses, with business outlooks and developments (R&D). Discover qualitative analyses (SWOT and STEP), company profiles and commercial developments. You also receive two interviews, and 90 tables, figures and charts

You will find prospects for key technology submarkets

In addition to analyses of the overall world market, you see revenue forecasting of five technology submarkets to 2024:
• RFID (radio frequency identification)
• Security printing
• Taggants
• Holograms/OVD (optical variable devices)
• Other pharma anti-counterfeiting technologies

Our investigation shows business research and analysis with individual revenue forecasts and discussions.

Prospects for leading countries are shown to 2024

Events and progress worldwide will influence the market, especially rising demand for supply chain security measures such as track-and-trace systems. Growth in this market will be fuelled by government mandates requiring serialisation solutions on products.

You discover individual revenue forecasts to 2024 for these geographical markets:
• US
Japan
Germany, France, UK, Italy and Spain (EU5 Countries, as a group)
Brazil
Russia
India
China
• RoW

The expected launch of new technologies from 2013 onwards will benefit regional and national markets. Greater uptake of existing technology worldwide will also stimulate the industry and market.

Companies and overall 2016 market revenue - what predicted growth?

Overall world revenue for pharmaceutical anti-counterfeiting technologies will reach $1.11bn in 2014. Rising concerns about counterfeit drugs worldwide will stimulate demand for drug security, authentication and verification solutions.

Our work profiles leading companies, assessing their technologies and products. You will see which technologies and organisations hold greatest potential.

In particular, we profile these leading organisations:
• 3M
• Authentix
• Alien Technology
• Colorcon
• NanoGuardian
• Thermo Scientific
• Angstrom Technologies
• AlpVision
Avery Dennison
• Chesapeake
• Covectra
• Everest Holovisions
• InkSure Technologies
• Covectra
• Intermec
• TruTag Technologies
• UPM Raflatac
• Zebra Technologies

What issues decide the future of the industry and market?

Our study lets you assess industry trends and outlooks. You will find discussions of many issues and developments, including R&D:
• Parallel trade of medical products
• Activities of trade bodies and governmental organisations
• Security and efficiency of the pharma supply chain
• Wholesalers and other pharma intermediaries
• Actions taken by pharma companies
• Trading channels and drug counterfeiters
• Standards, regulations and policies

You see discussions of social, technological, economic and political matters, with emphasis on competing organisations and those shaping policy. Find out what the future holds.

Our investigation gives you multi-level business research and analysis with sales forecasts. You will see how the industry and market can perform from 2014 to 2024.

How the Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2014-2024 report helps you

In summary, our report gives you the following knowledge:
• Revenues forecasts to 2024 for the overall world pharmaceutical anti-counterfeiting technologies market and 5 submarkets - discover the industry's prospects
• Revenues forecasts to 2024 for 5 pharmaceutical anti-counterfeiting technologies submarkets - discover promising areas for investments and revenues
• Market forecasting to 2024 for the 8 key regions: US, Japan, leading EU countries (Germany, France, the UK, Italy and Spain), India, China, Brazil and Russia
• Profiles of 17 prominent companies - assess product ranges, developments and strategies
• Competition and opportunities - see what factors affect the pharmaceutical anti-counterfeiting market, learning what shapes its future, esp. prospects for sustaining and developing business
• Opinions from our survey, seeing interviews with leading industry experts AlpVision and also a Leading Anti-counterfeiting Technologies Company Based in the US.

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed on business intelligence.

1. Executive Summary

1.1 Market Highlights
1.2 Overview of the Report Content
1.3 Research and Analysis Methods
1.4 Glossary of Terms Related to Pharmaceutical Anti-counterfeiting Technologies

2. Introduction to Pharmaceutical Counterfeiting

2.1 Drug Counterfeiting: A Thorn in the Side of the Pharma Industry
2.1.1 Regional Differences Hindering Information Exchange
2.1.2 Rising Counterfeiting Incidents in Developed Regions
2.2 The Most Commonly Counterfeited Drugs
2.3 Types of Counterfeit Drugs
2.3.1 Substandard Pharmaceutical Products as Counterfeits
2.3.2 Global Outsourcing of Active Pharmaceutical Ingredients (APIs)
2.3.2.1 Heparin Contamination
2.3.2.2 Stricter Enforcement needed for API Control
2.4 Why are Drugs Counterfeited?
2.4.1 Methods of Producing Pharmaceutical Counterfeits
2.4.2 Moving Counterfeits into the Pharmaceutical Supply Chain
2.4.3 Corruption Within the Pharmaceutical Distribution System
2.5 The Internet and its Role in Pharmaceutical Counterfeiting
2.5.1 Online Pharmacies: A Cheap Distribution System for Pharma Counterfeits
2.5.2 Legal Online Pharmacies: A Convenient and Quick Way of Dispensing Medication
2.5.3 Verifying the Authenticity of Online Pharmacies
2.6 Pharmaceutical Counterfeiting: The Global Costs
2.6.1 The Impact of Pharmaceutical Counterfeiting on Consumers
2.6.2 The Impact of Counterfeiting on Healthcare Providers
2.6.3 The Impact of Counterfeiting on Pharma Manufacturers
2.6.4 The Impact of Pharmaceutical Counterfeiting on Governments
2.6.5 The Impact of Counterfeiting on the Global Pharmaceutical Industry
2.6.5.1 Operation Pangea: Europol's Fight Against Counterfeiting
2.6.5.2 Legislative Deficiencies Aiding Counterfeiting Operations
2.7 Factors Fuelling Pharmaceutical Counterfeiting
2.7.1 An Erratic Supply or Shortage of Drugs Promotes Counterfeiting
2.7.2 Price Differentials and High Price Medicines Drive People to Cheaper Counterfeit Alternatives
2.7.3 Drug Misuse Creates a Market for Counterfeiting
2.7.4 Trade through Free-Trade Zones/Free Ports Is an Important Route for Counterfeiters
2.7.5 The Trade of Pharmaceuticals through Several Intermediaries Helps Hide Counterfeit Drugs
2.7.6 Counterfeiters Target Developed Markets
2.7.7 Parallel Trade - a Counterfeiting Route in Europe

3. Leading Technologies and Applications

3.1 Passive Technologies
3.1.1 Security Inks as Anti-counterfeiting Technologies
3.1.2 Holograms as Anti-counterfeiting Technologies
3.1.3 Visual Inspection as the First Line of Defence Against Drug Counterfeiting
3.1.4 Overt and Hidden Imaging
3.2 Active Technologies
3.2.1 Electromagnetic Tags - Radio Frequency Identification (RFID) as Anti-counterfeiting Technologies
3.2.2 Taggants as Anti-counterfeiting Technologies
3.2.3 Mass Encoding Technology
3.2.3.1 Digital Mass Serialisation Technology (DMS)
3.2.3.2 Digital Mass Encryption (DME)
3.2.3.3 Barcode Applications: Serialisation is Key

4. Leading Companies in the Pharmaceutical Anti-counterfeiting Technologies Market

4.1 3M: A Diversified Technology Multinational
4.2 Alien Technology: RFID Technology Specialist
4.3 AlpVision: Cryptoglyph Security Solution
4.3.1 Fingerprint: A 'Read Only' Technology
4.3.2 Krypsos Platform
4.3.3 Cryptoglyph
4.3.4 AlpVision: Integration of Phone Applications Important for Future Growth
4.4 Angstrom Technologies - Security Inks
4.5 Authentix: Product Authentication and Brand Protection
4.5.1 Product-specific Track-and-Trace Solutions
4.5.2 Packaging Solutions
4.6 Avery Dennison: RFID Technologies Expert
4.7 Colorcon
4.7.1 Colorcon's Taggants: On-Dose ID
4.7.2 Colorcon's Brand Enhancement Service
4.8 Chesapeake: Acquired by The Caryle Group
4.9 Covectra
4.9.1 Covectra's Authenti-Track System for Product Tracing
4.9.2 Covectra's ControlTrack System for Combating Opioid Drug Diversion
4.10 Everest Holovisions
4.11 InkSure Technologies: Leader in Cloud-based Authentication
4.12 Intermec: A Workflow Performance Company
4.12.1 Automatic Information Data Capture
4.12.2 Will Recent Acquisitions Spell an Uncertain Future?
4.13 NanoGuardian
4.13.1 NanoCodes: Data Carriers of Limitless Potential
4.13.2 NanoGuardian's Global Licensing Agreement with Capsugel
4.13.3 The Closed-Loop Protection System
4.13.4 Major Players Showing Interest In NanoGuardian's Technologies
4.14 ThermoFisher Scientific
4.14.1 Acquisition of Ahura Scientific
4.14.2 Continous Growth and Expansion into Emerging Markets
4.14.3 ThermoFisher Scientific's TruScan Technology
4.15 TruTag Technologies
4.15.1 TruTag's Silica Microtag Technology
4.16 UPM Raflatac
4.17 Zebra Technologies

5. Global Pharmaceutical Anti-counterfeiting Technologies Market 2014-2024

5.1 Pharmaceutical Anti-counterfeiting Technologies: Market Overview
5.1.1 Size of the Pharmaceutical Anti-counterfeiting Technologies Market in 2012 and
2013
5.1.2 Global Pharmaceutical Anti-counterfeiting Technologies Market: Growth Trends
5.1.3 Global Pharmaceutical Anti-counterfeiting Technologies Market Forecast 2012-2017
5.1.4 Global Pharmaceutical Anti-counterfeiting Technologies Market Forecast 2017-2024
5.1.5 Changing Market Shares by Sector, 2012-2024
5.2 Pharmaceutical RFID Market Forecast 2012-2024
5.3 Pharmaceutical Security Printing Market Forecast 2012-2024
5.4 Pharmaceutical Taggants Market Forecast 2012-2024
5.5 Pharmaceutical Hologram/OVD Market Forecast 2012-2024
5.6 Other Pharmaceutical Anti-counterfeiting Technologies Market Forecast 2012-2024

6. Leading National Markets 2014-2024

6.1 Pharmaceutical Counterfeiting: A Global Conundrum
6.1.1 How Will National Market Shares Change to 2024?
6.2 Regional Pharmaceutical Anti-counterfeiting Market Forecast, 2014-2024
6.2.1 The US Market
6.2.2 EU5: Europe's Leading Anti-counterfeiting Technology Markets
6.2.3 Japan: Uptake of Key Technologies Important for Market Growth
6.2.4 China: Set to See High Growth Rates Continue Until 2017
6.2.5 India: New Mandates will Help Deter Counterfeiters
6.2.5.1 Collaboration with the WHO will Help Regain Consumer Confidence in Pharma Products
6.2.6 Brazil: South America's Largest Pharmaceutical Market
6.2.7 Russia: Highest Per-Capita Spending on Healthcare of All the BRIC Nations

7. Issues Affecting the Pharmaceutical Anti-counterfeiting Technologies Market

7.1 SWOT Analysis of the Pharmaceutical Anti-counterfeiting Technologies Market, 2014-2024
7.2 Strengths
7.2.1 Growing Interest from Pharmaceutical Companies in Tackling Counterfeiting
7.2.1.1 AstraZeneca
7.2.1.2 GlaxoSmithKline
7.2.1.3 Johnson & Johnson
7.2.1.4 Novartis
7.2.1.5 Pfizer
7.2.1.6 Sanofi
7.2.2 Organisations Promoting the Awareness and Implementation of Anti-Counterfeiting Solutions
7.2.2.1 Anti-counterfeiting and Product Protection Programme (A-CAPPP)
7.2.2.2 Anti-counterfeiting Group (ACG)
7.2.2.3 Brazil's National Health Surveillance Agency (ANVISA)
7.2.2.4 Canadian Anti-counterfeiting Network (CACN)
7.2.2.5 Center for Healthcare Supply Chain Research
7.2.2.6 European Alliance for Access to Safe Medicines (EAASM)
7.2.2.7 European Federation of Pharmaceutical Industries and Associations (EFPIA)
7.2.2.8 International Anti-counterfeiting Coalition (IACC)
7.2.2.9 International Authentication Association (IAA)
7.2.2.10 The Pharmaceutical Security Institute (PSI)
7.2.3 Track-and-Trace Solutions Boosting Supply Chain Efficiency
7.2.4 New Technologies Providing More Comprehesive Anti-Counterfeiting Protection
7.2.5 Litigation Proceedings over Counterfeit Products Affecting Profitability
7.3 Weaknesses
7.3.1 The Lack of Standardisation Across the Industry as a Whole Will Impede Technology Adoption
7.3.2. Insufficient Quantitative Measurement of the Effectiveness of Anti-counterfeiting Technologies
7.3.2.1 Complexity of Factors Influencing Drug Revenue Makes Quantifying Commercial Impact of Anti-counterfeiting Technologies Difficult
7.3.3 Technology Reliability and the Ease of Integration into Manufacturing Processes
7.3.4 Lack of Cooperation Between Various Governmental Organisations Aids Drug
Counterfeiters
7.4 Opportunities
7.4.1 Constantly Evolving Technologies Allows for Product Innovation
7.4.2 Anti-counterfeiting Technologies for the Prevention of Online Fraud
7.5 Threats
7.5.1 The High Volume of Counterfeiting Activities Could Devalue Anti-counterfeiting
Solutions
7.5.2 Developing Countries Lack Infrastructure to Effectively Deal with Counterfeiting
7.5.3 Pace of Innovation May Not Keep up with the Counterfeiters
7.6 STEP Analysis of the Pharmaceutical Anti-counterfeiting Technologies Market, 2014-2024
7.6.1 Social Factors
7.6.1.1 The Weak Enforcement of Legislation
7.6.1.2 Corruption: A Hindrance to Eradicating Pharmaceutical Counterfeiting
7.6.1.3 Changing Public Perception and Consumer Education
7.6.1.4 Concerns Over Information Privacy
7.6.2 Technological Factors
7.6.2.1 Smartphone Read and Verify: A Customer Empowerment Tool
7.6.2.2 US FDA's Counterfeit Detection Device
7.6.2.3 UV and IR Inks Being Used Covertly for Increased Security
7.6.2.4 Bokode: A Potential Replacement for Barcodes?
7.6.2.5 SigNature DNA
7.6.3 Economic Factors
7.6.3.1 Implementation Costs of Anti-counterfeiting Technologies
7.6.3.2 Anti-counterfeiting Technologies Require R&D Investment
7.6.4 Political Factors
7.6.4.1 World Health Organization: The IMPACT Programme
7.6.4.2 Anti-Counterfeiting Trade Agreement (ACTA)
7.6.4.3 The Fagan Civil Case: Effects of Litigation on Players in the Drug Supply Chain
7.6.4.4 Legislations for Supply Chain Security
7.6.4.5 E-pedigree: A Catalyst for Product Serialisation
7.6.4.5.1 E-pedigree: Challenges Involved in Implementation
7.6.4.5.2 EU and the US: Differing Supply Chain Authentication
7.6.4.6 UK MHRA: Falsified Medical Products Strategy
7.6.4.7 The EU's Falsified Medicines Directive

8. Expert Opinions

8.1 Interview with Dr Fred Jordan, Chief Executive Officer, AlpVision
8.1.1 Current State of Counterfeiting in the Pharmaceutical Industry
8.1.2 AlpVison's Key Technologies and Strategies for Combating Counterfeiters
8.1.3 The Future of Anti-counterfeiting Technologies
8.1.4 On Whom do the Responsibilities for Counterfeiting Prevention Lie?
8.1.5 The Major Barriers Facing Implementation of Anti-counterfeiting Technologies
8.1.6 Future Growth Drivers of the Anti-counterfeiting Technologies Market
8.2 Interview with a Spokesperson from a Leading Anti-counterfeiting Technologies Company Based in the US.
8.2.1 On the Threats Posed by Counterfeit Products
8.2.2 Keeping Up with the Counterfeiters: An Impossible Task?
8.2.3 Duty of Care
8.2.4 DNA Technology: The Innovation Needed to Defeat Counterfeiting?
8.2.5 Future Prospects of the Pharma Anti-counterfeiting Industry

9. Conclusion

9.1 The Pharmaceutical Anti-counterfeiting Technologies Industry 2014-2024
9.2 Government Mandates Will Fuel Growth in the Market
9.3 The US Will Continue to Dominate the Market
9.4 New Directives Will Ensure Track-and-Trace Market Leadership
9.5 European Preference for Mandated 2D Barcode Technology
9.6 Improved Regulation of Online Pharmacies Necessary for Anti-counterfeiting Technologies to be Effective
9.7 Market Expansion Will be Dependent on the Development of Industry-Wide Standards for the Use of the Available Technologies

List of Tables

Table 2.1 Global Reported Incidents of Drug Counterfeiting, 2008-2012
Table 2.2 Classification of Counterfeit Pharmaceutical Products
Table 3.1 Anti-counterfeiting Technologies Used in the Pharmaceutical Industry
Table 3.2 Leading Anti-counterfeiting Security Ink Manufacturers, 2013
Table 3.3 Leading Anti-counterfeiting Holographic Labelling Manufacturers, 2013
Table 3.4 Leading Radio Frequency Identification (RFID) System Manufacturers, 2013
Table 3.5 Leading Pharmaceutical Taggants Manufacturers, 2013
Table 4.1 3M: Revenue ($m) and Revenue Shares (%) by Business Segment, 2012
Table 4.2 Alien Technologies: Types of RFID Readers Produced, 2013
Table 4.3 AlpVision: Products and Applications, 2013
Table 4.4 Angstrom Technologies: Products and Applications, 2013
Table 4.5 Avery Dennison: Revenue ($m) and Revenue Shares (%) by Business Segment, 2012
Table 4.6 Avery Dennison: RFID Products for Use in Pharmaceuticals, 2013
Table 4.7 Colorcon: Product Groups, Sub-groups, and Examples 2013
Table 4.8 Everest Holovision: Products and Applications, 2013
Table 4.9 InkSure Technologies: Products and Applications, 2013
Table 4.10 InkSure Technologies: Historical Revenue ($m, AGR %) 2009-2012
Table 4.11 Intermec: Product Lines and Descriptions, 2013
Table 4.12 Intermec: Historical Revenue ($m, AGR %) 2009-2012
Table 4.13 ThermoFisher Scientific: Historical Revenue ($bn) 2009-2012
Table 4.14 ThermoFisher Scientific: Revenue Shares (%) by Region, 2012
Table 4.15 UPM Raflatac: Product Groups and Descriptions, 2013
Table 4.16 Zebra Technologies: Product Groups and Descriptions, 2013
Table 4.17 Zebra Technologies: Historical Revenue ($m, AGR%) 2009-2012
Table 5.1 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) and Market Shares (%) by Sector, 2012
Table 5.2 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Revenue Forecast ($m, AGR%, CAGR%) by Sector, 2012-2017
Table 5.3 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Revenue Forecast ($m, AGR%, CAGR%) by Sector, 2017-2024
Table 5.4 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Revenue ($m) by Sector, 2012, 2017, 2024
Table 5.5 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Sector, 2012, 2017, 2024
Table 5.6 RFID: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 5.7 Security Printing: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 5.8 Pharmaceutical Taggants: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 5.9 Holograms/OVD: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 5.10 Other Technologies: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 6.1 The Global Pharmaceutical Anti-counterfeiting Technologies: Revenue Forecast ($m, AGR%, CAGR%) by Region, 2012-2017
Table 6.2 The Global Pharmaceutical Anti-counterfeiting Technologies: Revenue Forecast ($m, AGR%, CAGR%) by Region, 2017-2024
Table 6.3 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Region, 2012, 2017, 2024
Table 6.4 US Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 6.5 EU5 Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 6.6 Japanese Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 6.7 Chinese Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 6.8 Indian Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m, AGR%,
CAGR%), 2012-2024
Table 6.9 Brazilian Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 6.10 Russian Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 7.1 SWOT Analysis of the Pharmaceutical Anti-counterfeiting Technologies Industry, 2014-2024
Table 7.2 Selected Instances of Counterfeiting Activities, 2012-2013
Table 7.3 Selected Instances of Counterfeiting Activities, 2009-2011
Table 7.4 STEP Analysis for the Pharmaceutical Anti-counterfeiting Technologies Industry, 2014-2024

List of Figures

Figure 2.1 Global Reported Incidents of Drug Counterfeiting, 2008-2012
Figure 2.2 Flow Chart of the Route Taken by Counterfeit Pharma Products Entering the Legal Supply Chain
Figure 3.1 Holograms Anti-counterfeiting Technologies: Drivers and Restraints, 2014-2024
Figure 3.2 Basic Components of a RFID System
Figure 3.3 RFID Anti-counterfeiting Technologies: Drivers and Restraints, 2014-2024
Figure 3.4 Taggants Anti-counterfeiting Technologies: Drivers and Restraints, 2014-2024
Figure 3.5 Barcode Anti-counterfeiting Technologies: Drivers and Restraints, 2014-2024
Figure 4.1 3M: Revenue Shares (%) by Business Segment, 2012
Figure 4.2 Authentix's Global Monitoring Service: A Three Step Program
Figure 4.3 Avery Dennison: Revenue Shares (%) by Business Segment, 2012
Figure 4.4 InkSure Technologies: Historical Revenue ($m) 2009-2012
Figure 4.5 Intermec: Historical Revenue ($m) 2009-2012
Figure 4.6 ThermoFisher Scientific: Historical Revenue ($bn) 2009-2012
Figure 4.7 ThermoFisher Scientific: Revenue Shares (%) by Region, 2012
Figure 4.8 Zebra Technologies: Historical Revenue ($m) 2009-2012
Figure 5.1 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Sector, 2012
Figure 5.2 The Global Pharmaceutical Anti-counterfeiting Technologies: Revenue Forecast ($m), 2012- 2017
Figure 5.3 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Revenue Forecast ($m), 2017-2024
Figure 5.4 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Revenue ($m) by Sector, 2012, 2017, 2024
Figure 5.5 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Sector, 2012
Figure 5.6 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Sector, 2017
Figure 5.7 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Sector, 2024
Figure 5.8 RFID: Revenue Forecast ($m), 2012-2024
Figure 5.9 Security Printing: Revenue Forecast ($m), 2012-2024
Figure 5.10 Pharmaceutical Taggants: Revenue Forecast ($m), 2012-2024
Figure 5.11 Holograms/OVD: Revenue Forecast ($m), 2012-2024
Figure 5.12 Other Technologies Revenue Forecast ($m), 2012-2024
Figure 6.1 US and EU5 Pharmaceutical Anti-counterfeiting Technologies: Revenue Forecast ($m), 2012-2024
Figure 6.2 China, India, Brazil and Russia Pharmaceutical Anti-counterfeiting Technologies Market: Revenue Forecast ($m), 2012-2024
Figure 6.3 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Region, 2012
Figure 6.4 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Region, 2017
Figure 6.5 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Region, 2024
Figure 6.6 US Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m), 2012-2024
Figure 6.7 EU5 Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m), 2012-2024
Figure 6.8 Japanese Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m), 2012-2024
Figure 6.9 Chinese Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m), 2012-2024
Figure 6.10 Indian Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m), 2012-2024
Figure 6.11 Brazilian Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m), 2012-2024
Figure 6.12 Russian Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m), 2012-2024
Figure 7.1 EU Supply Chain Authentication Strategy, 2013
Figure 7.2 US Supply Chain Authentication Strategy, 2013
Figure 9.1 Global Pharmaceutical Anti-counterfeiting Market: RFID, Security Printing, Holograms/OVD, and Taggants Revenue Forecast ($m), 2012-2024

Companies Listed

3M
Adhesives Research
Ahura Scientific
Alien Technologies
AlpVision
Altegrity Risk International
American Academy of Pediatrics (AAP)
American Express
AmerisourceBergen
Angstrom Technologies
Anti-Counterfeiting and Product Protection Programme (A-CAPPP)
Anti-Counterfeiting Group (ACG)
Apoteket
Applied DNA Sciences
ARmark Authentication Technologies LLC
AstraZeneca
Australian Therapeutic Goods Administration (TGA)
Authentix
Automation
Avery Dennison
Axway
Baxter
Canadian Anti-Counterfeiting Network (CACN)
Capsugel
Cellular Bioengineering Inc.
Center for Healthcare Supply Chain Research
Center for Medicine in the Public Interest (US)
CFC International
Chesapeake
Colorcon
Cortegra
Covectra
Digital China
Directorate General of Foreign Trade [India]
Domino
Drugs Standard Control Organisation
DuPont
European Alliance for Access to Safe Medicines (EAASM)
European Commission
European Directorate for the Quality of Medicines and Healthcare (EDQM),
European Federation of Pharmaceutical Industries and Associations (EFPIA)
European Medicines Agency
Europol
Everest Holovisions
GlaxoSmithKline (GSK)
Google
Healthcare Distribution Management Association (HDMA)
Heart UK
Hologram Industries
Holomex
HOMAI (hologram manufactures association of India)
Honeywell International
Image Solutions
Impinj Inc
Ingenia Technology
InkSure Technologies
Intermec/ Interface Mechanisms
International Anti-counterfeiting Association (IAA)
International Anti-Counterfeiting Coalition (IACC)
International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
International Ink Company
International Medical Products Anti-Counterfeiting Taskforce (IMPACT)
International Policy Network
Interpol
Japanese Pharmaceutical Manufacturers Association (JPMA)
Johnson & Johnson
Kodak
Loughborough University
LaserLock
Massachusetts Institute of Technology (MIT)
MasterCard
Medicines and Healthcare products Regulatory Agency (MHRA)
Medicrime Convention Council
Menasha Corporation
MicroTag Temed Ltd
Microtrace Solutions
Motorola
NanoGuardian
NanoInk Inc.
Nanotech Security Corp.
National Agency for Food and Drug Administration and Control (NAFDAC) [Nigeria]
National Association of Boards of Pharmacy (NABP)
National Health Surveillance Agency (ANVISA)
Neri Labels
Novartis
Novavision
OEP Technologie BV
One Equity Partners
OpSec Security
Organisation for Economic Co-operation and Development (OECD)
Pacific Holographics
Paralec Inc
Partner for Safe Medicines (PSM) India
Pera Innovations
Pfizer
Pharmaceutical Research and Manufacturers of America (PhRMA)
PharmaSecure
Quality Brands Protection Committee (QBPC) [China]
Reckitt Benckiser
Roche
Royal Pharmaceutical Society of Great Britain (RPSGB)
Sanofi
Savi Technology
ScanSource
Scientific Protein Laboratories (SPL)
SICPA
Siemens
Smartrac
South Dakota School of Mines and Technology
State Food and Drug Administration (SFDA) [China]
Sun Chemical
Symbol Technologies
Systech
Tagsys RFID
Teva Pharmaceuticals
Texas Instruments
The Caryle Group
The International Hologram Manufacturers Association
The Patients Association (UK)
The Pharmaceutical Security Institute (PSI)
ThermoFisher Scientific
TruTag Technologies
United Nations
University of South Dakota
UPM
UPM Kymmene
UPM Raflatac
UPM Rafsec z
US Center for Safe Internet Pharmacies (CSIP)
US Food and Drugs Agency (FDA)
US Pharmacopeial Convention (USP)
Visa
Vocollect Inc
Voxtel
Webscan
World Customs Organization
World Health Organization (WHO)
World Intellectual Property Organization (WIPO)
Zebra Technologies

To order this report: Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2014-2024
http://www.reportlinker.com/p0572966/Pharmaceutical-Anti-counterfeiting-Technologies-Market-Analysis-2014-2024.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

@ThingsExpo Stories
"MobiDev is a software development company and we do complex, custom software development for everybody from entrepreneurs to large enterprises," explained Alan Winters, U.S. Head of Business Development at MobiDev, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
Large industrial manufacturing organizations are adopting the agile principles of cloud software companies. The industrial manufacturing development process has not scaled over time. Now that design CAD teams are geographically distributed, centralizing their work is key. With large multi-gigabyte projects, outdated tools have stifled industrial team agility, time-to-market milestones, and impacted P&L stakeholders.
"Akvelon is a software development company and we also provide consultancy services to folks who are looking to scale or accelerate their engineering roadmaps," explained Jeremiah Mothersell, Marketing Manager at Akvelon, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
"Space Monkey by Vivent Smart Home is a product that is a distributed cloud-based edge storage network. Vivent Smart Home, our parent company, is a smart home provider that places a lot of hard drives across homes in North America," explained JT Olds, Director of Engineering, and Brandon Crowfeather, Product Manager, at Vivint Smart Home, in this SYS-CON.tv interview at @ThingsExpo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
In his session at 21st Cloud Expo, Carl J. Levine, Senior Technical Evangelist for NS1, will objectively discuss how DNS is used to solve Digital Transformation challenges in large SaaS applications, CDNs, AdTech platforms, and other demanding use cases. Carl J. Levine is the Senior Technical Evangelist for NS1. A veteran of the Internet Infrastructure space, he has over a decade of experience with startups, networking protocols and Internet infrastructure, combined with the unique ability to it...
"IBM is really all in on blockchain. We take a look at sort of the history of blockchain ledger technologies. It started out with bitcoin, Ethereum, and IBM evaluated these particular blockchain technologies and found they were anonymous and permissionless and that many companies were looking for permissioned blockchain," stated René Bostic, Technical VP of the IBM Cloud Unit in North America, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Conventi...
Gemini is Yahoo’s native and search advertising platform. To ensure the quality of a complex distributed system that spans multiple products and components and across various desktop websites and mobile app and web experiences – both Yahoo owned and operated and third-party syndication (supply), with complex interaction with more than a billion users and numerous advertisers globally (demand) – it becomes imperative to automate a set of end-to-end tests 24x7 to detect bugs and regression. In th...
"Cloud Academy is an enterprise training platform for the cloud, specifically public clouds. We offer guided learning experiences on AWS, Azure, Google Cloud and all the surrounding methodologies and technologies that you need to know and your teams need to know in order to leverage the full benefits of the cloud," explained Alex Brower, VP of Marketing at Cloud Academy, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clar...
Widespread fragmentation is stalling the growth of the IIoT and making it difficult for partners to work together. The number of software platforms, apps, hardware and connectivity standards is creating paralysis among businesses that are afraid of being locked into a solution. EdgeX Foundry is unifying the community around a common IoT edge framework and an ecosystem of interoperable components.
Coca-Cola’s Google powered digital signage system lays the groundwork for a more valuable connection between Coke and its customers. Digital signs pair software with high-resolution displays so that a message can be changed instantly based on what the operator wants to communicate or sell. In their Day 3 Keynote at 21st Cloud Expo, Greg Chambers, Global Group Director, Digital Innovation, Coca-Cola, and Vidya Nagarajan, a Senior Product Manager at Google, discussed how from store operations and ...
"There's plenty of bandwidth out there but it's never in the right place. So what Cedexis does is uses data to work out the best pathways to get data from the origin to the person who wants to get it," explained Simon Jones, Evangelist and Head of Marketing at Cedexis, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
SYS-CON Events announced today that CrowdReviews.com has been named “Media Sponsor” of SYS-CON's 22nd International Cloud Expo, which will take place on June 5–7, 2018, at the Javits Center in New York City, NY. CrowdReviews.com is a transparent online platform for determining which products and services are the best based on the opinion of the crowd. The crowd consists of Internet users that have experienced products and services first-hand and have an interest in letting other potential buye...
SYS-CON Events announced today that Telecom Reseller has been named “Media Sponsor” of SYS-CON's 22nd International Cloud Expo, which will take place on June 5-7, 2018, at the Javits Center in New York, NY. Telecom Reseller reports on Unified Communications, UCaaS, BPaaS for enterprise and SMBs. They report extensively on both customer premises based solutions such as IP-PBX as well as cloud based and hosted platforms.
It is of utmost importance for the future success of WebRTC to ensure that interoperability is operational between web browsers and any WebRTC-compliant client. To be guaranteed as operational and effective, interoperability must be tested extensively by establishing WebRTC data and media connections between different web browsers running on different devices and operating systems. In his session at WebRTC Summit at @ThingsExpo, Dr. Alex Gouaillard, CEO and Founder of CoSMo Software, presented ...
WebRTC is great technology to build your own communication tools. It will be even more exciting experience it with advanced devices, such as a 360 Camera, 360 microphone, and a depth sensor camera. In his session at @ThingsExpo, Masashi Ganeko, a manager at INFOCOM Corporation, introduced two experimental projects from his team and what they learned from them. "Shotoku Tamago" uses the robot audition software HARK to track speakers in 360 video of a remote party. "Virtual Teleport" uses a multip...
A strange thing is happening along the way to the Internet of Things, namely far too many devices to work with and manage. It has become clear that we'll need much higher efficiency user experiences that can allow us to more easily and scalably work with the thousands of devices that will soon be in each of our lives. Enter the conversational interface revolution, combining bots we can literally talk with, gesture to, and even direct with our thoughts, with embedded artificial intelligence, whic...
SYS-CON Events announced today that Evatronix will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Evatronix SA offers comprehensive solutions in the design and implementation of electronic systems, in CAD / CAM deployment, and also is a designer and manufacturer of advanced 3D scanners for professional applications.
Leading companies, from the Global Fortune 500 to the smallest companies, are adopting hybrid cloud as the path to business advantage. Hybrid cloud depends on cloud services and on-premises infrastructure working in unison. Successful implementations require new levels of data mobility, enabled by an automated and seamless flow across on-premises and cloud resources. In his general session at 21st Cloud Expo, Greg Tevis, an IBM Storage Software Technical Strategist and Customer Solution Architec...
To get the most out of their data, successful companies are not focusing on queries and data lakes, they are actively integrating analytics into their operations with a data-first application development approach. Real-time adjustments to improve revenues, reduce costs, or mitigate risk rely on applications that minimize latency on a variety of data sources. In his session at @BigDataExpo, Jack Norris, Senior Vice President, Data and Applications at MapR Technologies, reviewed best practices to ...
An increasing number of companies are creating products that combine data with analytical capabilities. Running interactive queries on Big Data requires complex architectures to store and query data effectively, typically involving data streams, an choosing efficient file format/database and multiple independent systems that are tied together through custom-engineered pipelines. In his session at @BigDataExpo at @ThingsExpo, Tomer Levi, a senior software engineer at Intel’s Advanced Analytics gr...